在医院治疗慢性阻塞性肺病 (COPD) 的临床决策支持系统:系统性审查
Adeola Bamgboje-Ayodele1, David N Borg2,3, Steven M McPhail2,3
1Biomedical Informatics and Digital Health, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Digital health
|December 13, 2023
概括
慢性阻塞性肺病 (COPD) 的临床决策支持系统 (CDS) 在医院环境中显示出混合的有效性. 需要进一步的研究来优化实施和评估它们对患者和临床医生的结果的影响.
科学领域:
- 医疗信息学 医疗信息学
- 肺部病理学 肺部病理学
- 医疗技术 医疗技术 医学技术
背景情况:
- 慢性阻塞性肺病 (COPD) 管理需要有效的临床决策支持 (CDS).
- 医院环境中COPD CDS系统的现有文献正在出现,但需要综合.
- 了解这些系统的影响和实施对于改善患者护理至关重要.
研究的目的:
- 综合关于COPD的CDS系统的文献.
- 描述现有的COPDCDS系统,它们对结果的影响,以及实施障碍/促进者.
主要方法:
- 在五个数据库中进行了系统的文献搜索.
- 包括的研究描述了临床医生面临的COPD CDS系统在医院和医院在家环境.
- 在RE-AIM框架的指导下进行了定性叙事合成.
主要成果:
- 包括12项研究,重点关注医院 (n=7) 和家庭医院 (n=5) 设置.
- 实施范围报告很少,观察到采用率低至中等.
- CDS系统的有效性是混合的;在一项研究中报告了促进者,但没有报告障碍和维护策略.
结论:
- 在医院环境中用于COPD的CDS系统代表着一个重要的,正在发展的研究领域.
- 目前的系统往往针对医生,描述不完整,评估有限.
- 有机会优化和评估COPDCDS系统的实施和影响,专注于患者,临床医生和医疗服务结果.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.9K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.9K
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
COPD: Management Using Bronchodilators and Corticosteroids
213
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
213


